Increasing clinicians’ suspicion of ATTR amyloidosis using a retrospective algorithm

Jan 15, 2026

News

Launch a New Era IN Discover

Sep 25, 2026

Janny’s Fundraiser Page

Mar 28, 2026

Amyloidosis Therapeutic Market to Worth Over US$ 6.37 Billion by 2033 | Astute Analytica

Feb 21, 2026

CMAF Donates $160,000 in 2025 to Support Amyloidosis Research, Awareness, and Support

Feb 20, 2026

What Is Multiple Myeloma? Explained Clearly for Those Who Are Newly Diagnosed

Feb 12, 2026

More in News

Education

Clinical Features of Systemic Amyloidosis: A Scoping Review

Jan 27, 2026

AL Cardiac Amyloidosis Presenting as Grade 3 ATTR Mimicry on Scintigraphy

Jan 23, 2026

https://www.oreateai.com/blog/understanding-hattr-a-deep-dive-into-hereditary-transthyretin-amyloidosis/23903414f6a0a602d9aca557d23f138c

Jan 21, 2026

AL Cardiac Amyloidosis Presenting as Grade 3 ATTR Mimicry on Scintigraphy

Jan 21, 2026

How to Manage Nerve Damage if You Have ATTR-CM

Jan 20, 2026

More in Education

Community Center

The “Mixed Phenotype” Mystery: Why Your hATTR Diagnosis Might Only Be Half the Story

Jan 28, 2026

How Rare Cancer Saved My Life

Jan 15, 2026

My Journey with Amyloidosis: Turning Fear into Purpose

Jan 15, 2026

My Amyloid Story Christine Giosa

Jan 15, 2026

A Second Chance at Life: Gurmit’s Story

Jan 13, 2026

More in Community Center

Video